Glanzmann thrombasthenia (GT) is a rare blood clotting disorder. It’s caused by genetic mutations that affect your platelets, and it can make you more prone to excess bleeding. Chances are, you ...

Hemab Therapeutics, a clinical-stage biotechnology company developing novel prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders, today announced a total of 11 ...